Vaccination Failure
10
2
2
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
10.0%
1 terminated out of 10 trials
66.7%
-19.8% vs benchmark
20%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
Immune Response After SARS-CoV-2 (COVID-19) Vaccination in a Context of Non-Hodgkin Lymphoma
Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?
Preterm Immune System Development and Response to Immunization
Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen
Timeliness and Completeness of Routine Childhood Vaccinations by 2 Years of Age in Nigeria.
EXTENSION OF THE EUROPEAN E-BUG PROJECT
Safety, Immunogenicity And Efficacy Of Vaccination In Military Personnel
Automated SMS Reminders to Parents on Their Cell Phones Can Significantly Improve the on Time Vaccination Rates Children in Pakistan
SMS Reminders to Improve the on Time Vaccination Rates Among Children in Pakistan
Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine